E-Z-EM buys into virtual colonoscopy firm

Article

The world’s largest manufacturer of contrast agents for gastrointestinal radiology has taken a 5% equity position in PointDx, an emerging medical technology company focused on the development of virtual colonoscopy software and structured reporting

The world’s largest manufacturer of contrast agents for gastrointestinal radiology has taken a 5% equity position in PointDx, an emerging medical technology company focused on the development of virtual colonoscopy software and structured reporting solutions for radiology. The deal also provides E-Z-EM with a three-year warrant to purchase an additional 120,000 shares and one seat on the PointDx board of directors. By taking an equity stake in PointDx, E-Z-EM hopes to follow and support the development of new applications in GI medicine.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
New Research Examines Radiation Risks with CT Exposure Prior to Pregnancy
Diagnostic Imaging’s Weekly Scan: August 31 — September 6
New Echocardiography Research Suggests Emerging Marker for Cardiomyopathy Detection in Patients with Duchenne Muscular Dystrophy
© 2025 MJH Life Sciences

All rights reserved.